Goodwin Procter LLP advised JMI Equity on the deal while Taft Stettinius & Hollister represented Greenlight Guru.
Greenlight Guru, pioneer of the only dedicated Medical Device Success Platform (MDSP) has received a $120 million investment from JMI Equity (“JMI”), a growth equity firm focused on investing in leading software companies.
Over the past year, medical device companies were forced to adapt to many changes, including a tsunami of global regulatory updates, an increased need for cloud-based software due to remote work, and a rise in supply chain management issues. Greenlight Guru’s industry-specific software has proven critical in helping medical device companies thrive in spite of challenging, unpredictable times. Its all-in-one medical device success platform enables device companies across the globe to bring products to market faster by streamlining the registration, approval, and certification processes while providing a single source of truth for quality, product development, and regulatory management.
This investment from JMI will enable Greenlight Guru to accelerate product development efforts, rapidly expand its product capabilities across the patient-centric value chain, and support significant global growth.
JMI is a growth equity firm focused on investing in leading software companies.
Greenlight Guru is an all-in-one medical device success platform helping solve the unique challenges of device makers across their entire product’s lifecycle.
The Goodwin team was led by Brian McPeake (Picture), Matthew Raby, and Ana Sanderson.
Taft’s legal team included Brad Schwer, Ronan Johnson, Michael Myers, and Helen Jazzar.
Involved fees earner: Brian McPeake – Goodwin Procter; Matthew Raby – Goodwin Procter; Ana Sanderson – Goodwin Procter; Helen Jazzar – Taft Stettinius & Hollister; Ronan Johnson – Taft Stettinius & Hollister; Michael Myers – Taft Stettinius & Hollister; Brad Schwer – Taft Stettinius & Hollister;